What is Peritoneal Cancer?

Peritoneal cancer is a type of cancer that affects the peritoneum, the thin layer of tissue that lines the abdomen and covers the abdominal organs. This cancer originates in the peritoneum and can spread to other organs in the abdomen. The exact cause of peritoneal cancer is not always clear, but it is often associated with other types of cancer that have spread to the peritoneum.

Additionally, certain risk factors such as a family history of cancer, age, and genetic mutations may increase the likelihood of developing peritoneal cancer. Understanding the causes of peritoneal cancer is essential in raising awareness and promoting early detection and treatment.

What Are the Symptoms of Peritoneal Cancer

Peritoneal cancer can present with various symptoms that may include abdominal pain or swelling, unexplained weight loss, changes in bowel habits, fatigue, and a feeling of fullness even after eating small amounts.

Some individuals may also experience nausea, vomiting, and bloating. It's essential to consult a healthcare provider if you notice persistent or worsening symptoms, as early detection can improve treatment outcomes. Regular check-ups and screenings can help in the early detection and management of peritoneal cancer.

Persistent abdominal pain or discomfort, especially in the lower abdomen, can be a symptom of peritoneal cancer.
Unexplained weight loss or decreased appetite may indicate the presence of peritoneal cancer.
Abdominal bloating or swelling that does not improve with time could be a sign of peritoneal cancer.
Changes in bowel habits, such as constipation or diarrhea, can sometimes be associated with peritoneal cancer.
Feeling full quickly while eating, even small amounts of food, might be a symptom of peritoneal cancer.

Get a second opinion from trusted experts and makeconfident, informed decisions.

Get Second Opinion

Causes of Peritoneal Cancer

One of the primary causes is exposure to asbestos, a mineral known to increase the risk of developing this type of cancer. Additionally, genetic factors and mutations, such as those in the BRCA1 and BRCA2 genes, can also play a role in the development of peritoneal cancer.

Chronic inflammation in the peritoneal cavity, often due to conditions like endometriosis or pelvic inflammatory disease, is another contributing factor. These cumulative influences can lead to the abnormal growth of cells in the peritoneum, resulting in peritoneal cancer.

Genetic mutations, such as BRCA1 and BRCA2, can increase the risk of developing peritoneal cancer.
Chronic inflammation within the peritoneum may lead to the development of peritoneal cancer over time.
Exposure to asbestos fibers has been linked to an increased risk of developing peritoneal cancer.
Family history of certain cancers, like ovarian cancer, can predispose individuals to peritoneal cancer.
Lynch syndrome, a hereditary condition, can elevate the likelihood of developing peritoneal cancer.

Types Of Peritoneal Cancer

Peritoneal cancer encompasses various types that originate in the peritoneum, a thin membrane lining the abdominal cavity. The primary types include primary peritoneal cancer, which develops in the peritoneum itself; peritoneal mesothelioma, a rare cancer linked to asbestos exposure; and peritoneal carcinomatosis, which refers to the spread of cancer from other organs to the peritoneum.

These cancers share the commonality of affecting the peritoneal tissue but may differ in terms of their specific characteristics, treatment approaches, and prognosis. Early detection and personalised treatment are crucial in managing peritoneal cancer effectively.

Primary peritoneal cancer originates in the peritoneum, a thin layer of tissue lining the abdomen.
Peritoneal mesothelioma is a rare cancer linked to asbestos exposure affecting the peritoneum.
Pseudomyxoma peritonei is a type of peritoneal cancer characterized by the production of mucin within the abdominal cavity.
Peritoneal carcinomatosis refers to cancer spread to the peritoneum from other organs, such as the ovaries or colon.
Malignant peritoneal mesothelioma is an aggressive form of cancer affecting the peritoneum, often associated with asbestos exposure.

Risk Factors

Peritoneal cancer, a rare type of cancer affecting the peritoneum lining the abdomen, has several risk factors that may increase the likelihood of its development. These include a history of asbestos exposure, a family history of certain hereditary cancer syndromes such as Lynch syndrome or BRCA mutations, chronic inflammation in the peritoneum due to conditions like endometriosis, and a previous diagnosis of ovarian, colorectal, or breast cancer. Additionally, age, gender, and genetic factors can also play a role in the risk of developing peritoneal cancer. It's essential to be aware of these risk factors and discuss any concerns with a healthcare provider for early detection and management.

Age over 60 years old increases the risk of developing peritoneal cancer.
A family history of ovarian, breast, or colorectal cancer can elevate the likelihood of peritoneal cancer.
Inherited genetic mutations, such as BRCA1 and BRCA2 gene mutations, are associated with an increased risk of peritoneal cancer.
Exposure to asbestos or certain industrial chemicals may raise the risk of developing peritoneal cancer.
Endometriosis, a condition where tissue similar to the lining of the uterus grows outside the uterus, is a risk factor for peritoneal cancer.

Your health is everything - prioritize your well-being today.

Schedule Your Appointment

Diagnosis of Peritoneal Cancer

The process commonly starts with a thorough physical examination and medical history review. Following this, imaging tests like CT scans, MRIs, or ultrasounds are often conducted to visualize the peritoneal area and detect any abnormalities.

To confirm the diagnosis, a biopsy is generally performed, where a sample of tissue is collected for laboratory analysis. In some cases, a laparoscopy may be needed for a direct visual inspection of the peritoneum. Blood tests to assess tumor markers can also be helpful in the diagnostic process. Overall, a combination of these methods helps in accurately diagnosing peritoneal cancer.

Imaging tests such as CT scans can help detect peritoneal cancer by visualizing abnormalities in the abdominal area.
Biopsies are crucial in diagnosing peritoneal cancer, involving the removal of tissue samples for laboratory analysis.
Blood tests may be conducted to assess tumor markers that can indicate the presence of peritoneal cancer.

Treatment for Peritoneal Cancer

Treatment options for Peritoneal Cancer typically involve a multidisciplinary approach tailored to each individual's specific situation. Commonly employed treatments may include surgery to remove tumors, chemotherapy to target cancer cells, and sometimes radiation therapy. In some cases, targeted therapy or immunotherapy may also be considered.

Additionally, patients may benefit from palliative care to manage symptoms and improve quality of life. The selection of treatment modalities depends on factors such as the stage of the cancer, overall health of the patient, and treatment goals. Close collaboration between oncologists, surgeons, and other healthcare professionals is crucial in developing a comprehensive treatment plan for Peritoneal Cancer.

Surgery is a common treatment option for peritoneal cancer, involving the removal of cancerous tissues in the peritoneum.
Hyperthermic intraperitoneal chemotherapy (HIPEC) is a specialized procedure that delivers heated chemotherapy directly into the abdomen during surgery to target any remaining cancer cells.
Chemotherapy drugs, such as paclitaxel and carboplatin, may be administered systemically to help destroy cancer cells throughout the body.
Targeted therapy drugs, like bevacizumab, work by targeting specific molecules involved in cancer growth to inhibit tumor progression.
Immunotherapy can be used to stimulate the body's immune system to recognize and attack cancer cells in the peritoneum.

Find Our Specialists

Book Doctor Appointment